Brief: Armata Pharmaceuticals Files Prospectus Related To Disposition Of Up To 2.1 Million
29/03/2022 21:10
March 29 (Reuters) - Armata Pharmaceuticals Inc ARMP.A :
* ARMATA PHARMACEUTICALS FILES PROSPECTUS RELATES TO
DISPOSITION
FROM TIME TO TIME OF UP TO 2.1 MILLION SHARES OF COMMON STOCK BY
SELLING SHAREHOLDERS
Further company coverage: ARMP.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Armata Pharmaceuticals
See all newsBrief: Armata Pharmaceuticals Announces First Quarter 2026 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Delays Announcement Of Fourth Quarter And Full-Year 2025 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product Designation
Armata Pharma jumps on US FDA nod for late-stage infection trial
Brief: Armata Pharmaceuticals Commissions cGMP Manufacturing Facility In Los Angeles